Literature DB >> 9060658

Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly.

M Li1, T P Cripe, P A Estes, M K Lyon, R C Rose, R L Garcea.   

Abstract

The L1 major capsid protein of human papillomavirus type 11 (HPV-11) was expressed in Escherichia coli, and the soluble recombinant protein was purified to near homogeneity. The recombinant L1 protein bound DNA as determined by the Southwestern assay method, and recombinant mutant L1 proteins localized the DNA-binding domain to the carboxy-terminal 11 amino acids of L1. Trypsin digestion of the full-length L1 protein yielded a discrete 42-kDa product (trpL1), determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, resulting from cleavage at R415, 86 amino acids from the L1 carboxy terminus. Sucrose gradient sedimentation analysis demonstrated that trpL1 sedimented at 11S, while L1 proteins with amino-terminal deletions of 29 and 61 residues sedimented at 4S. Electron microscopy showed that the full-length L1 protein appeared as pentameric capsomeres which self-assembled into capsid-like particles. The trpL1 protein also had a pentameric morphology but was unable to assemble further. In an enzyme-linked immunosorbent assay, the trpL1 and L1 capsids reacted indistinguishably from virus-like particles purified after expression of HPV-11 L1 in insect cells. The carboxy terminus of L1 therefore constitutes the interpentamer linker arm responsible for HPV-11 capsid formation, much like the carboxy-terminal domain of the polyomavirus VP1 protein. The trypsin susceptibility of HPV-11 L1 capsids suggests a possible mechanism for virion disassembly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060658      PMCID: PMC191427     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Structural polypeptides of rabbit, bovine, and human papillomaviruses.

Authors:  M Favre
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

2.  Site-directed mutation affecting polyomavirus capsid self-assembly in vitro.

Authors:  R L Garcea; D M Salunke; D L Caspar
Journal:  Nature       Date:  1987 Sep 3-9       Impact factor: 49.962

3.  In vitro assay for protein-protein interaction: carboxyl-terminal 40 residues of simian virus 40 structural protein VP3 contain a determinant for interaction with VP1.

Authors:  E Gharakhanian; J Takahashi; J Clever; H Kasamatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Self-assembly of purified polyomavirus capsid protein VP1.

Authors:  D M Salunke; D L Caspar; R L Garcea
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Divalent ion-dependent reversible swelling of tomato bushy stunt virus and organization of the expanded virion.

Authors:  J Krüse; K M Krüse; J Witz; C Chauvin; B Jacrot; A Tardieu
Journal:  J Mol Biol       Date:  1982-12-05       Impact factor: 5.469

6.  Metal-free southern bean mosaic virus crystals.

Authors:  I Rayment; J E Johnson; M G Rossmann
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

7.  DNA-binding activity of papillomavirus proteins.

Authors:  R G Mallon; D Wojciechowicz; V Defendi
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a.

Authors:  J Doorbar; P H Gallimore
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

9.  Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments.

Authors:  T Stehle; S C Harrison
Journal:  Structure       Date:  1996-02-15       Impact factor: 5.006

10.  Polyoma virus major capsid protein, VP1. Purification after high level expression in Escherichia coli.

Authors:  A D Leavitt; T M Roberts; R L Garcea
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

View more
  41 in total

1.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Current status of human papillomavirus vaccines.

Authors:  Barbara Ma; Richard Roden; T-C Wu
Journal:  J Formos Med Assoc       Date:  2010-07       Impact factor: 3.282

3.  In vitro gene transfer using human papillomavirus-like particles.

Authors:  A Touze; P Coursaget
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

Review 4.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

5.  Chaperone-mediated in vitro disassembly of polyoma- and papillomaviruses.

Authors:  Laura R Chromy; Amy Oltman; Patricia A Estes; Robert L Garcea
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 6.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

7.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Authors:  R C Rose; W I White; M Li; J A Suzich; C Lane; R L Garcea
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Robert C Rose; Edward E Walsh
Journal:  Virol J       Date:  2009-06-18       Impact factor: 4.099

10.  Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.

Authors:  Archana Monie; Chien-Fu Hung; Richard Roden; T-C Wu
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.